Ab&B Bio-Tech CO., LTD. JS Class H (HK:2627)
:2627
Want to see HK:2627 full AI Analyst Report?
Total Valuation
Ab&B Bio-Tech CO., LTD. JS Class H has a market cap or net worth of HK$11.54B. The enterprise value is HK$10.11B.
Market CapHK$11.54B
Enterprise ValueHK$10.11B
Share Statistics
Ab&B Bio-Tech CO., LTD. JS Class H has 296,361,850 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding296,361,850
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Ab&B Bio-Tech CO., LTD. JS Class H’s return on equity (ROE) is -1.76 and return on invested capital (ROIC) is -21.64%.
Return on Equity (ROE)-1.76
Return on Assets (ROA)-0.16
Return on Invested Capital (ROIC)-21.64%
Return on Capital Employed (ROCE)-0.33
Revenue Per Employee445.30K
Profits Per Employee-443.77K
Employee Count583
Asset Turnover0.16
Inventory Turnover1.87
Valuation Ratios
The current PE Ratio of Ab&B Bio-Tech CO., LTD. JS Class H is ―. Ab&B Bio-Tech CO., LTD. JS Class H’s PEG ratio is 1.22.
PE Ratio―
PS Ratio47.37
PB Ratio83.89
Price to Fair Value83.89
Price to FCF-30.77
Price to Operating Cash Flow-315.11
PEG Ratio1.22
Income Statement
In the last 12 months, Ab&B Bio-Tech CO., LTD. JS Class H had revenue of 259.61M and earned -258.72M in profits. Earnings per share was -0.66.
Revenue259.61M
Gross Profit151.46M
Operating Income-229.09M
Pretax Income-258.72M
Net Income-258.72M
EBITDA-181.80M
Earnings Per Share (EPS)-0.66
Cash Flow
In the last 12 months, operating cash flow was -31.88M and capital expenditures -47.00M, giving a free cash flow of -78.88M billion.
Operating Cash Flow-31.88M
Free Cash Flow-78.88M
Free Cash Flow per Share-0.27
Dividends & Yields
Ab&B Bio-Tech CO., LTD. JS Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.22
52-Week Price Change-32.91%
50-Day Moving Average40.88
200-Day Moving Average―
Relative Strength Index (RSI)49.64
Average Volume (3m)183.66K
Important Dates
Ab&B Bio-Tech CO., LTD. JS Class H upcoming earnings date is Mar 31, 2026, Before Open (Confirmed).
Last Earnings DateAug 28, 2025
Next Earnings DateMar 31, 2026
Ex-Dividend Date―
Financial Position
Ab&B Bio-Tech CO., LTD. JS Class H as a current ratio of 0.55, with Debt / Equity ratio of 2770.65%
Current Ratio0.55
Quick Ratio0.48
Debt to Market Cap0.07
Net Debt to EBITDA-4.00
Interest Coverage Ratio-12.93
Taxes
In the past 12 months, Ab&B Bio-Tech CO., LTD. JS Class H has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Ab&B Bio-Tech CO., LTD. JS Class H EV to EBITDA ratio is -71.64, with an EV/FCF ratio of -32.59.
EV to Sales50.17
EV to EBITDA-71.64
EV to Free Cash Flow-32.59
EV to Operating Cash Flow-65.28
Balance Sheet
Ab&B Bio-Tech CO., LTD. JS Class H has HK$118.78M in cash and marketable securities with HK$1.02B in debt, giving a net cash position of -HK$902.84M billion.
Cash & Marketable SecuritiesHK$118.78M
Total DebtHK$1.02B
Net Cash-HK$902.84M
Net Cash Per Share-HK$3.05
Tangible Book Value Per ShareHK$0.31
Margins
Gross margin is 85.46%, with operating margin of -88.24%, and net profit margin of -99.65%.
Gross Margin85.46%
Operating Margin-88.24%
Pretax Margin-99.65%
Net Profit Margin-99.65%
EBITDA Margin-70.03%
EBIT Margin-92.83%
Analyst Forecast
The average price target for Ab&B Bio-Tech CO., LTD. JS Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―